Epigenetica: un nuovo approccio per la diagnosi dei disordini muscolo scheletrici

Title

Code

DNAm profiling

Type

Sperimentale

Start Year

2024

Status

In Corso

Principal Investigator

051-6366186, 340-2643380

giovanni.trisolino@ior.it

Trisolino Giovanni, MD

Pediatric Orthopedics and Traumatology

Operational unit that carry out the study

complex unit

Ortopedia e Traumatologia Pediatrica

Director

Rocca Gino, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. DNAm profiling

Tuesday 30 January 2024, 17:00

PG0001334_2024_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Epigenetica: un nuovo approccio per la diagnosi dei disordini muscolo scheletrici

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Epigenetica: un nuovo approccio per la diagnosi dei disordini muscolo scheletrici

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in